isogranulatimide (Alethia Biotherapeutics)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Nameisogranulatimide (Alethia Biotherapeutics)
Drug Alias Nameisogranulatimideisogranulatimide (University of British Columbia)AB-IsoG
ClassificationSmall moleculesNatural product/Extract
Mechanisms of ActionCheckpoint kinase inhibitors
TargetsCheckpoint kinase
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesThe University Of British Columbia
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesThe University Of British ColumbiaAlethia Biotherapeutics Inc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A